![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Pharma/Fine Chemicals Roundup – February 78:32 AM MST | February 7, 2012 | Deepti Ramesh LONZA REPLACES CEO AFTER DECLINE IN EARNINGS Lonza has suddenly fired CEO Stefan Borgas following a series of weak financial results. The company announced plans last month to appoint a new CEO and, during a transitional period Rolf Soiron, Lonza chairman, will coordinate its management committee. The weak results follow Lonza’s acquisition of biocides maker Arch Chemicals (Norwalk, CT) for $1.4 billion last October. “With the acquisition of Arch in 2011, Lonza achieved another step in its transformation toward a global life science company,”... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|